Biocon Limited has informed the Exchange regarding a press release dated January 28, 2026, titled "S&P Global Upgrades Biocon Biologics Credit Rating To BB+ Revises Outlook to Stable ".
Biocon Limited has informed the Exchange regarding a press release dated January 28, 2026, titled "S&P Global Upgrades Biocon Biologics Credit Rating To BB+ Revises Outlook to Stable ".